Korean Stock Flows

Hlb Pharmaceutical (KRX: 047920)

HLB제약 KOSDAQ Biotech & Pharma 자연과학 및 공학 연구개발업
Close (Oct 13, 2026)
₩11,940
-1.49%
Market cap
₩1T ($0.4B)
52-week range
₩5,529 – ₩20,503
P/E (trailing) · P/B · Div yield
91.85 · 3.40 · 0%

Who is buying Hlb Pharmaceutical?

Between Sep 10, 2026 and Oct 13, 2026 (20 trading sessions), foreign investors net sold ₩4.6bn ($3M) of Hlb Pharmaceutical, the 109th largest foreign net sale among 1828 KOSDAQ stocks. Institutions net sold ₩9.8bn ($7M) and retail investors net bought ₩14.5bn ($11M) over the same window. Foreigners were net buyers on 6 of the 20 sessions.

Foreign investors hold 0% of Hlb Pharmaceutical's listed shares (KRX ownership data as of Oct 13, 2026), compared with 0% twenty sessions earlier and 1.47% a year ago.

The stock closed at ₩11,940 on Oct 13, 2026: +73.80% over 20 sessions, -19.22% year-to-date, -4.09% over one year. The 52-week range is ₩5,529 – ₩20,503.

At ₩11,940 the stock trades at 91.85× trailing earnings (KRX, last completed fiscal year); no analyst consensus is available for a forward P/E.

Hlb Pharmaceutical share price, last 60 trading days (KRW)
13,577 10,798 8,018 5,239 Jul 13 Aug 26 Oct 13
Daily foreign investor net purchases, last 60 trading days
+9.4bn +4.7bn -4.7bn -9.4bn Jul 13 Aug 26 Oct 13
View chart data as a table
Date Close Foreign net Institutions Retail
2026-10-13 ₩11,940 ₩-0.6bn ₩-1.3bn +₩1.7bn
2026-10-12 ₩12,120 ₩-1.0bn ₩-0.1bn +₩1.1bn
2026-10-08 ₩13,130 ₩-8.9bn +₩0.0bn +₩8.8bn
2026-10-07 ₩12,570 ₩-3.1bn +₩0.4bn +₩2.8bn
2026-10-06 ₩13,010 +₩9.4bn ₩-0.8bn ₩-8.6bn
2026-10-02 ₩10,010 ₩-0.5bn ₩-5.1bn +₩5.6bn
2026-10-01 ₩11,150 ₩-0.8bn ₩-0.5bn +₩1.3bn
2026-09-30 ₩11,770 ₩-0.5bn ₩-0.3bn +₩0.8bn
2026-09-29 ₩12,030 +₩0.2bn ₩-0.4bn +₩0.1bn
2026-09-28 ₩9,620 ₩-0.0bn +₩0.2bn ₩-0.2bn
2026-09-23 ₩7,400 +₩0.2bn ₩-0.0bn ₩-0.2bn
2026-09-22 ₩7,440 ₩-0.2bn ₩-0.0bn +₩0.2bn
2026-09-21 ₩7,650 +₩1.6bn ₩-0.7bn ₩-0.8bn
2026-09-18 ₩6,210 ₩-0.2bn ₩-0.1bn +₩0.3bn
2026-09-17 ₩6,510 +₩0.0bn ₩-0.2bn +₩0.1bn
2026-09-16 ₩6,600 ₩-0.1bn ₩-0.0bn +₩0.1bn
2026-09-15 ₩6,700 +₩0.3bn ₩-0.2bn ₩-0.1bn
2026-09-14 ₩6,450 ₩-0.0bn ₩-0.1bn +₩0.1bn
2026-09-11 ₩6,630 ₩-0.2bn ₩-0.1bn +₩0.3bn
2026-09-10 ₩6,600 ₩-0.3bn ₩-0.6bn +₩0.9bn
2026-09-09 ₩6,870 +₩0.2bn ₩-0.0bn ₩-0.2bn
2026-09-08 ₩7,030 ₩-1.0bn ₩-1.4bn +₩2.2bn
2026-09-07 ₩7,610 +₩0.1bn ₩-0.1bn ₩-0.0bn
2026-09-04 ₩7,870 ₩-0.1bn ₩-0.0bn +₩0.1bn
2026-09-03 ₩7,640 ₩-0.0bn ₩-0.0bn +₩0.1bn
2026-09-02 ₩7,370 +₩0.2bn +₩0.0bn ₩-0.2bn
2026-09-01 ₩7,770 ₩-1.8bn ₩0.0bn +₩1.8bn
2026-08-31 ₩7,110 ₩-0.1bn ₩0.0bn +₩0.1bn
2026-08-28 ₩7,230 +₩0.1bn ₩0.0bn ₩-0.1bn
2026-08-27 ₩7,200 +₩0.1bn +₩0.0bn ₩-0.1bn
2026-08-26 ₩7,250 ₩-0.2bn ₩0.0bn +₩0.2bn
2026-08-25 ₩7,630 +₩0.2bn ₩-0.0bn ₩-0.2bn
2026-08-24 ₩7,580 ₩-0.1bn +₩0.0bn +₩0.1bn
2026-08-21 ₩7,850 ₩-0.1bn ₩-0.0bn +₩0.1bn
2026-08-20 ₩8,130 ₩-0.2bn +₩0.0bn +₩0.2bn
2026-08-19 ₩8,430 ₩-0.3bn ₩0.0bn +₩0.3bn
2026-08-18 ₩8,740 ₩-0.1bn ₩-0.0bn +₩0.1bn
2026-08-14 ₩8,800 ₩-0.0bn ₩0.0bn +₩0.1bn
2026-08-13 ₩8,720 ₩-0.2bn +₩0.0bn +₩0.2bn
2026-08-12 ₩8,790 +₩0.0bn ₩-0.0bn ₩-0.0bn
2026-08-11 ₩8,830 +₩0.0bn ₩-0.0bn ₩-0.0bn
2026-08-10 ₩8,740 +₩1.1bn +₩0.0bn ₩-1.1bn
2026-08-07 ₩8,390 ₩-0.0bn +₩0.0bn +₩0.0bn
2026-08-06 ₩8,320 ₩-0.3bn +₩0.0bn +₩0.4bn
2026-08-05 ₩8,380 +₩0.2bn ₩0.0bn ₩-0.2bn
2026-08-04 ₩8,240 +₩0.6bn ₩-0.0bn ₩-0.6bn
2026-08-03 ₩7,630 +₩1.4bn ₩-0.0bn ₩-1.3bn
2026-07-31 ₩7,510 +₩0.5bn +₩0.0bn ₩-0.5bn
2026-07-30 ₩7,307 +₩0.0bn ₩0.0bn ₩-0.0bn
2026-07-29 ₩7,787 +₩0.0bn +₩0.0bn +₩0.2bn
2026-07-28 ₩7,685 ₩-0.0bn +₩0.0bn ₩-0.2bn
2026-07-27 ₩7,943 ₩-0.0bn ₩-0.0bn +₩0.1bn
2026-07-24 ₩8,312 ₩-0.4bn +₩0.0bn +₩0.3bn
2026-07-23 ₩7,436 +₩0.1bn ₩0.0bn ₩-0.1bn
2026-07-22 ₩7,372 +₩0.1bn ₩-0.0bn ₩-0.1bn
2026-07-21 ₩7,989 ₩-1.5bn ₩0.0bn +₩1.4bn
2026-07-20 ₩7,427 +₩1.1bn +₩0.0bn ₩-1.1bn
2026-07-16 ₩8,634 ₩-2.4bn +₩0.0bn +₩2.3bn
2026-07-15 ₩7,906 ₩-0.9bn ₩0.0bn +₩0.9bn
2026-07-14 ₩6,082 ₩-0.0bn ₩0.0bn ₩-0.0bn
2026-07-13 ₩5,686 +₩0.6bn ₩-0.0bn +₩0.6bn

Investor flows summary

Window Foreign (USD) Institutions Retail
1 day ₩-0.6bn $-0M ₩-1.3bn +₩1.7bn
5 days ₩-4.1bn $-3M ₩-1.8bn +₩5.8bn
20 days ₩-4.6bn $-3M ₩-9.8bn +₩14.5bn

Positive = net buying, negative = net selling. Values aggregate the KRX main board and the NXT alternative venue.

Frequently asked questions

Are foreign investors buying Hlb Pharmaceutical stock?

Over the last 5 sessions foreign investors net sold ₩4.1bn ($3M) of Hlb Pharmaceutical; over 60 sessions they net sold ₩8.1bn ($6M); since Jan 1, 2026 they net sold ₩12.1bn ($9M). Over 20 sessions the stock is the 109th largest foreign net sale among 1828 KOSDAQ stocks.

How much of Hlb Pharmaceutical do foreign investors own?

Foreign investors own 0% of Hlb Pharmaceutical's shares as of Oct 13, 2026, versus 1.47% one year earlier. The figure is KRX's daily foreign holdings divided by listed shares, and it reflects trades settled through the previous session.

Who is on the other side — institutions or retail investors?

Over 20 sessions institutions net sold ₩9.8bn ($7M) and retail investors net bought ₩14.5bn ($11M) of Hlb Pharmaceutical. Retail investors have been absorbing what foreigners and institutions are selling.

Is Hlb Pharmaceutical listed on KOSPI or KOSDAQ?

Hlb Pharmaceutical (HLB제약) trades on KOSDAQ under KRX code 047920 in the Biotech & Pharma group, with a market capitalization of ₩1T ($0.4B). Daily net flows by investor type are published by KRX after each session and combine the KRX main board with the NXT venue.

Annual financials

Fiscal year Revenue YoY Operating profit Net income
2023 ₩136bn ($102M) – -₩20bn (-$15M) -₩19bn (-$15M)
2024 ₩137bn ($103M) +0.80% ₩1bn ($1M) ₩2bn ($2M)
2025 ₩206bn ($154M) +50.00% ₩1bn ($1M) ₩5bn ($3M)

Consolidated (K-IFRS) where available, from DART regulatory filings. USD figures converted at the current rate (₩1333.09/$) for reference only.

← All foreign investor flows